5-35667166-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_024867.4(SPEF2):c.1262G>A(p.Arg421His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,612,356 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0072 ( 2 hom., cov: 33)
Exomes 𝑓: 0.012 ( 137 hom. )
Consequence
SPEF2
NM_024867.4 missense
NM_024867.4 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 3.37
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0092085).
BP6
Variant 5-35667166-G-A is Benign according to our data. Variant chr5-35667166-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 403482.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00724 (1102/152298) while in subpopulation SAS AF= 0.0141 (68/4826). AF 95% confidence interval is 0.0114. There are 2 homozygotes in gnomad4. There are 517 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPEF2 | NM_024867.4 | c.1262G>A | p.Arg421His | missense_variant | 9/37 | ENST00000356031.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPEF2 | ENST00000356031.8 | c.1262G>A | p.Arg421His | missense_variant | 9/37 | 1 | NM_024867.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00725 AC: 1103AN: 152180Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
1103
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00768 AC: 1917AN: 249766Hom.: 11 AF XY: 0.00838 AC XY: 1131AN XY: 134902
GnomAD3 exomes
AF:
AC:
1917
AN:
249766
Hom.:
AF XY:
AC XY:
1131
AN XY:
134902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0121 AC: 17631AN: 1460058Hom.: 137 Cov.: 31 AF XY: 0.0122 AC XY: 8847AN XY: 726176
GnomAD4 exome
AF:
AC:
17631
AN:
1460058
Hom.:
Cov.:
31
AF XY:
AC XY:
8847
AN XY:
726176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00724 AC: 1102AN: 152298Hom.: 2 Cov.: 33 AF XY: 0.00694 AC XY: 517AN XY: 74476
GnomAD4 genome
AF:
AC:
1102
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
517
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
49
ALSPAC
AF:
AC:
55
ESP6500AA
AF:
AC:
15
ESP6500EA
AF:
AC:
117
ExAC
AF:
AC:
943
Asia WGS
AF:
AC:
15
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Candidate PCD gene, but frequency is high - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | SPEF2: BP4, BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;D;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;M;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;.;D;D
REVEL
Benign
Sift
Uncertain
D;D;.;D;D
Sift4G
Uncertain
D;D;.;D;D
Polyphen
D;D;.;D;.
Vest4
MVP
MPC
0.056
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at